nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0389	0.0546	CbGbCtD
Reboxetine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0389	0.0544	CbGbCtD
Reboxetine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0366	0.0513	CbGbCtD
Reboxetine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0366	0.0513	CbGbCtD
Reboxetine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0351	0.0492	CbGbCtD
Reboxetine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0331	0.0464	CbGbCtD
Reboxetine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0331	0.0464	CbGbCtD
Reboxetine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0303	0.0425	CbGbCtD
Reboxetine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0294	0.0413	CbGbCtD
Reboxetine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0286	0.04	CbGbCtD
Reboxetine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0277	0.0389	CbGbCtD
Reboxetine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0266	0.0373	CbGbCtD
Reboxetine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0266	0.0373	CbGbCtD
Reboxetine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0255	0.0358	CbGbCtD
Reboxetine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0251	0.0352	CbGbCtD
Reboxetine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0251	0.0352	CbGbCtD
Reboxetine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0248	0.0347	CbGbCtD
Reboxetine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0233	0.0326	CbGbCtD
Reboxetine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0233	0.0326	CbGbCtD
Reboxetine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0211	0.0295	CbGbCtD
Reboxetine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0211	0.0295	CbGbCtD
Reboxetine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0197	0.0277	CbGbCtD
Reboxetine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0182	0.0255	CbGbCtD
Reboxetine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0247	CbGbCtD
Reboxetine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.016	0.0224	CbGbCtD
Reboxetine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.016	0.0224	CbGbCtD
Reboxetine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0153	0.0214	CbGbCtD
Reboxetine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00208	0.106	CbGeAlD
Reboxetine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00179	0.0912	CbGeAlD
Reboxetine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000875	0.0447	CbGeAlD
Reboxetine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000861	0.044	CbGeAlD
Reboxetine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000687	0.0351	CbGeAlD
Reboxetine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000665	0.034	CbGeAlD
Reboxetine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000654	0.0334	CbGeAlD
Reboxetine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.00063	0.0322	CbGeAlD
Reboxetine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000619	0.0316	CbGeAlD
Reboxetine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000573	0.0293	CbGeAlD
Reboxetine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00056	0.0286	CbGeAlD
Reboxetine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000539	0.0276	CbGeAlD
Reboxetine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000531	0.0271	CbGeAlD
Reboxetine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000511	0.0261	CbGeAlD
Reboxetine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000505	0.0258	CbGeAlD
Reboxetine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000467	0.0239	CbGeAlD
Reboxetine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00045	0.023	CbGeAlD
Reboxetine—HTR2C—brain—acquired immunodeficiency syndrome	0.000428	0.0219	CbGeAlD
Reboxetine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000406	0.0207	CbGeAlD
Reboxetine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000357	0.0183	CbGeAlD
Reboxetine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000345	0.0176	CbGeAlD
Reboxetine—ABCB1—retina—acquired immunodeficiency syndrome	0.000339	0.0173	CbGeAlD
Reboxetine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000336	0.0172	CbGeAlD
Reboxetine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000331	0.0169	CbGeAlD
Reboxetine—CYP3A4—blood—acquired immunodeficiency syndrome	0.00032	0.0164	CbGeAlD
Reboxetine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000315	0.0161	CbGeAlD
Reboxetine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00026	0.0133	CbGeAlD
Reboxetine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000256	0.0131	CbGeAlD
Reboxetine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00025	0.0128	CbGeAlD
Reboxetine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000246	0.0126	CbGeAlD
Reboxetine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000241	0.0123	CbGeAlD
Reboxetine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000238	0.0122	CbGeAlD
Reboxetine—ABCB1—blood—acquired immunodeficiency syndrome	0.000227	0.0116	CbGeAlD
Reboxetine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000219	0.0112	CbGeAlD
Reboxetine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000219	0.0112	CbGeAlD
Reboxetine—ABCB1—vagina—acquired immunodeficiency syndrome	0.00021	0.0107	CbGeAlD
Reboxetine—ABCB1—lung—acquired immunodeficiency syndrome	0.000199	0.0102	CbGeAlD
Reboxetine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000737	CcSEcCtD
Reboxetine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000735	CcSEcCtD
Reboxetine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000196	0.000735	CcSEcCtD
Reboxetine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000735	CcSEcCtD
Reboxetine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000196	0.01	CbGeAlD
Reboxetine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000195	0.000731	CcSEcCtD
Reboxetine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000731	CcSEcCtD
Reboxetine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.00073	CcSEcCtD
Reboxetine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000729	CcSEcCtD
Reboxetine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000726	CcSEcCtD
Reboxetine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000726	CcSEcCtD
Reboxetine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000193	0.000725	CcSEcCtD
Reboxetine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000724	CcSEcCtD
Reboxetine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000724	CcSEcCtD
Reboxetine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000193	0.000724	CcSEcCtD
Reboxetine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000193	0.000724	CcSEcCtD
Reboxetine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000192	0.00072	CcSEcCtD
Reboxetine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000719	CcSEcCtD
Reboxetine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.000718	CcSEcCtD
Reboxetine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000717	CcSEcCtD
Reboxetine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000717	CcSEcCtD
Reboxetine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000717	CcSEcCtD
Reboxetine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000191	0.000716	CcSEcCtD
Reboxetine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000715	CcSEcCtD
Reboxetine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000714	CcSEcCtD
Reboxetine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000713	CcSEcCtD
Reboxetine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000713	CcSEcCtD
Reboxetine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000712	CcSEcCtD
Reboxetine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000711	CcSEcCtD
Reboxetine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000711	CcSEcCtD
Reboxetine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000189	0.00071	CcSEcCtD
Reboxetine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.000709	CcSEcCtD
Reboxetine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000708	CcSEcCtD
Reboxetine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000189	0.000707	CcSEcCtD
Reboxetine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000188	0.000705	CcSEcCtD
Reboxetine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000705	CcSEcCtD
Reboxetine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000704	CcSEcCtD
Reboxetine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000703	CcSEcCtD
Reboxetine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000701	CcSEcCtD
Reboxetine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000701	CcSEcCtD
Reboxetine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000701	CcSEcCtD
Reboxetine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000699	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000698	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000696	CcSEcCtD
Reboxetine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000695	CcSEcCtD
Reboxetine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000695	CcSEcCtD
Reboxetine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000184	0.00941	CbGeAlD
Reboxetine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000184	0.00069	CcSEcCtD
Reboxetine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000689	CcSEcCtD
Reboxetine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.000689	CcSEcCtD
Reboxetine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000688	CcSEcCtD
Reboxetine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000686	CcSEcCtD
Reboxetine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000685	CcSEcCtD
Reboxetine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000685	CcSEcCtD
Reboxetine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000183	0.000685	CcSEcCtD
Reboxetine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000684	CcSEcCtD
Reboxetine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000684	CcSEcCtD
Reboxetine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000182	0.000683	CcSEcCtD
Reboxetine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000182	0.000683	CcSEcCtD
Reboxetine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000681	CcSEcCtD
Reboxetine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000681	CcSEcCtD
Reboxetine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00068	CcSEcCtD
Reboxetine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.00068	CcSEcCtD
Reboxetine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000679	CcSEcCtD
Reboxetine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000679	CcSEcCtD
Reboxetine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000677	CcSEcCtD
Reboxetine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000677	CcSEcCtD
Reboxetine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000674	CcSEcCtD
Reboxetine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000179	0.000672	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000672	CcSEcCtD
Reboxetine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000671	CcSEcCtD
Reboxetine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000669	CcSEcCtD
Reboxetine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000667	CcSEcCtD
Reboxetine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000177	0.00906	CbGeAlD
Reboxetine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000665	CcSEcCtD
Reboxetine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000663	CcSEcCtD
Reboxetine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000662	CcSEcCtD
Reboxetine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000662	CcSEcCtD
Reboxetine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.000662	CcSEcCtD
Reboxetine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000661	CcSEcCtD
Reboxetine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000176	0.00066	CcSEcCtD
Reboxetine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000659	CcSEcCtD
Reboxetine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000659	CcSEcCtD
Reboxetine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000658	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000658	CcSEcCtD
Reboxetine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.000657	CcSEcCtD
Reboxetine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000655	CcSEcCtD
Reboxetine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000655	CcSEcCtD
Reboxetine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000654	CcSEcCtD
Reboxetine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000652	CcSEcCtD
Reboxetine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000652	CcSEcCtD
Reboxetine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000174	0.000651	CcSEcCtD
Reboxetine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000174	0.000651	CcSEcCtD
Reboxetine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.00065	CcSEcCtD
Reboxetine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000173	0.00065	CcSEcCtD
Reboxetine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000648	CcSEcCtD
Reboxetine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000173	0.000647	CcSEcCtD
Reboxetine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000646	CcSEcCtD
Reboxetine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000645	CcSEcCtD
Reboxetine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000643	CcSEcCtD
Reboxetine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000643	CcSEcCtD
Reboxetine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000642	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000641	CcSEcCtD
Reboxetine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000641	CcSEcCtD
Reboxetine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000638	CcSEcCtD
Reboxetine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000638	CcSEcCtD
Reboxetine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000637	CcSEcCtD
Reboxetine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000637	CcSEcCtD
Reboxetine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000636	CcSEcCtD
Reboxetine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00017	0.000636	CcSEcCtD
Reboxetine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000169	0.000634	CcSEcCtD
Reboxetine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000634	CcSEcCtD
Reboxetine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000631	CcSEcCtD
Reboxetine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000168	0.000631	CcSEcCtD
Reboxetine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000168	0.00063	CcSEcCtD
Reboxetine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00063	CcSEcCtD
Reboxetine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00063	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000629	CcSEcCtD
Reboxetine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000168	0.000629	CcSEcCtD
Reboxetine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000168	0.000628	CcSEcCtD
Reboxetine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000628	CcSEcCtD
Reboxetine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000627	CcSEcCtD
Reboxetine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.000627	CcSEcCtD
Reboxetine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000167	0.000625	CcSEcCtD
Reboxetine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000167	0.000625	CcSEcCtD
Reboxetine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000624	CcSEcCtD
Reboxetine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000623	CcSEcCtD
Reboxetine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000623	CcSEcCtD
Reboxetine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.000622	CcSEcCtD
Reboxetine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000165	0.00062	CcSEcCtD
Reboxetine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000165	0.000619	CcSEcCtD
Reboxetine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000618	CcSEcCtD
Reboxetine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000164	0.000616	CcSEcCtD
Reboxetine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000615	CcSEcCtD
Reboxetine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000164	0.000614	CcSEcCtD
Reboxetine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00061	CcSEcCtD
Reboxetine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000609	CcSEcCtD
Reboxetine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000607	CcSEcCtD
Reboxetine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000606	CcSEcCtD
Reboxetine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000605	CcSEcCtD
Reboxetine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000605	CcSEcCtD
Reboxetine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000602	CcSEcCtD
Reboxetine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000602	CcSEcCtD
Reboxetine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000601	CcSEcCtD
Reboxetine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000601	CcSEcCtD
Reboxetine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000601	CcSEcCtD
Reboxetine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000599	CcSEcCtD
Reboxetine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000598	CcSEcCtD
Reboxetine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000596	CcSEcCtD
Reboxetine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.000594	CcSEcCtD
Reboxetine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000594	CcSEcCtD
Reboxetine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000593	CcSEcCtD
Reboxetine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.000593	CcSEcCtD
Reboxetine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000593	CcSEcCtD
Reboxetine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00059	CcSEcCtD
Reboxetine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000587	CcSEcCtD
Reboxetine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000586	CcSEcCtD
Reboxetine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000156	0.000584	CcSEcCtD
Reboxetine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000583	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000582	CcSEcCtD
Reboxetine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000579	CcSEcCtD
Reboxetine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000579	CcSEcCtD
Reboxetine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000578	CcSEcCtD
Reboxetine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000578	CcSEcCtD
Reboxetine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000577	CcSEcCtD
Reboxetine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000576	CcSEcCtD
Reboxetine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000576	CcSEcCtD
Reboxetine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000576	CcSEcCtD
Reboxetine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.000573	CcSEcCtD
Reboxetine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000571	CcSEcCtD
Reboxetine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000564	CcSEcCtD
Reboxetine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000561	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00056	CcSEcCtD
Reboxetine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00056	CcSEcCtD
Reboxetine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000556	CcSEcCtD
Reboxetine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000556	CcSEcCtD
Reboxetine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000555	CcSEcCtD
Reboxetine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000552	CcSEcCtD
Reboxetine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000552	CcSEcCtD
Reboxetine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000551	CcSEcCtD
Reboxetine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000551	CcSEcCtD
Reboxetine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.00055	CcSEcCtD
Reboxetine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000547	CcSEcCtD
Reboxetine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000547	CcSEcCtD
Reboxetine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000546	CcSEcCtD
Reboxetine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000545	CcSEcCtD
Reboxetine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000543	CcSEcCtD
Reboxetine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000538	CcSEcCtD
Reboxetine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000537	CcSEcCtD
Reboxetine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000536	CcSEcCtD
Reboxetine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000535	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000534	CcSEcCtD
Reboxetine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000533	CcSEcCtD
Reboxetine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000533	CcSEcCtD
Reboxetine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000533	CcSEcCtD
Reboxetine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000531	CcSEcCtD
Reboxetine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000529	CcSEcCtD
Reboxetine—ABCB1—brain—acquired immunodeficiency syndrome	0.000141	0.00719	CbGeAlD
Reboxetine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000523	CcSEcCtD
Reboxetine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000521	CcSEcCtD
Reboxetine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000515	CcSEcCtD
Reboxetine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000515	CcSEcCtD
Reboxetine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000513	CcSEcCtD
Reboxetine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000513	CcSEcCtD
Reboxetine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000513	CcSEcCtD
Reboxetine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.00051	CcSEcCtD
Reboxetine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000136	0.00695	CbGeAlD
Reboxetine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000508	CcSEcCtD
Reboxetine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000508	CcSEcCtD
Reboxetine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000506	CcSEcCtD
Reboxetine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000505	CcSEcCtD
Reboxetine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000504	CcSEcCtD
Reboxetine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000499	CcSEcCtD
Reboxetine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000497	CcSEcCtD
Reboxetine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000492	CcSEcCtD
Reboxetine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000489	CcSEcCtD
Reboxetine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000489	CcSEcCtD
Reboxetine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000484	CcSEcCtD
Reboxetine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000484	CcSEcCtD
Reboxetine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000482	CcSEcCtD
Reboxetine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.00048	CcSEcCtD
Reboxetine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.00048	CcSEcCtD
Reboxetine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000479	CcSEcCtD
Reboxetine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000478	CcSEcCtD
Reboxetine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000477	CcSEcCtD
Reboxetine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000466	CcSEcCtD
Reboxetine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000463	CcSEcCtD
Reboxetine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000461	CcSEcCtD
Reboxetine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.00046	CcSEcCtD
Reboxetine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000459	CcSEcCtD
Reboxetine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000457	CcSEcCtD
Reboxetine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000456	CcSEcCtD
Reboxetine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000453	CcSEcCtD
Reboxetine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000446	CcSEcCtD
Reboxetine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000444	CcSEcCtD
Reboxetine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000444	CcSEcCtD
Reboxetine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000433	CcSEcCtD
Reboxetine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000429	CcSEcCtD
Reboxetine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000429	CcSEcCtD
Reboxetine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000425	CcSEcCtD
Reboxetine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000425	CcSEcCtD
Reboxetine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000424	CcSEcCtD
Reboxetine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000422	CcSEcCtD
Reboxetine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000413	CcSEcCtD
Reboxetine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000409	CcSEcCtD
Reboxetine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000409	CcSEcCtD
Reboxetine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000409	CcSEcCtD
Reboxetine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000406	CcSEcCtD
Reboxetine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Reboxetine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000394	CcSEcCtD
Reboxetine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00039	CcSEcCtD
Reboxetine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00039	CcSEcCtD
Reboxetine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000388	CcSEcCtD
Reboxetine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Reboxetine—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.8e-05	0.000368	CcSEcCtD
